Is the rising incidence of breast cancer a consequence of lifestyle?;Mammacancer - En livsstilssygdom?

Ugeskrift for Laeger

Volumn 167, Issue 49, 2005, Pages 4636-4641

  Kroman, Niels T ^a   Lidegaard, Øjvind ^b   Kvistgaard, Marianne Ewertz ^b  

^a Brystkirurgisk Afdeling F   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL CONSUMPTION; BREAST CANCER; DENMARK; HUMAN; INCIDENCE; LIFESTYLE; OBESITY; REVIEW; RISK FACTOR; ADOLESCENT; ADULT; BREAST TUMOR; DRINKING BEHAVIOR; FEMALE; GENETIC PREDISPOSITION; GENETICS; HORMONE SUBSTITUTION; MENARCHE; PARITY; PREGNANCY;

ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ALCOHOL DRINKING; BREAST NEOPLASMS; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GRAVIDITY; HORMONE REPLACEMENT THERAPY; HUMANS; LIFE STYLE; MENARCHE; OVERWEIGHT; PARITY; PREGNANCY; RISK FACTORS;

EID: 33644790185     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Ewertz M, Duffy SW. Incidence of female breast cancer in relation to prevalence of risk factors in Denmark. Int J Cancer 1994;56:783-7.
2. Oksbjerg S, Mellemkjær L, Johansen C. Incidens og mortalitet af brystkræft hos kvinder i Danmark 1943-1992. Ugeskr Læger 1997;159:7134-40.
3. Cuzick J. Epidemiology of breast cancer-selected highlights. Breast 2003;12:405-11.
4. Lichtenstein P, Holm NV, Verkasalo PK et al. Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000;343:78-85.
5. Pharoah PD, Antoniou A, Bobrow M et al. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 2002;31:33-6.
6. Ahlgren M, Melbye M, Wohlfahrt J et al. Growth patterns and the risk of breast cancer in women. N Engl J Med 2004;351:1619-26.
7. Russo J, Tay LK, Russo IH. Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat 1982;2:5-73.
8. Chepko G, Smith GH. Three division-competent, structurally-distinct cell populations contribute to murine mammary epithelial renewal. Tissue Cell 1997;29:239-53.
9. Pike MC, Krailo MD, Henderson BE et al. "Hormonal" risk factors, "breast tissue age" and the age-incidence of breast cancer. Nature 1983;303:767-70.
10. Lanmann PH, Hoffmann K, Allen N et al. Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer 2004;111:762-71.
11. Coutelle C, Hohn B, Benesova M et al. Risk factors in alcohol associated breast cancer: alcohol dehydrogenase polymorphism and estrogens. Int J Oncol 2004;25:1127-32.
12. Johansen C, Olsen JH. Psykologisk stress, forekomst af kræftsygdom og årsagsspecifik dødelighed. Ugeskr Læger 1998;160:2699-703.
13. Hjerl K, Andersen EW, Keiding N et al. Breast cancer risk among women with psychiatric admission with affective or neurotic disorders: a nationwide cohort study in Denmark. Br J Cancer 1999;81:907-11.
14. Guth AA. Breast cancer and human immunodeficiency virus infection: issues for the 21st century. J Womens Health (Larchmt) 2003;12:227-32.
15. Stewart T, Tsai S-CJ, Grayson H et al. Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation. Lancet 1995;346:796-8.
16. Helm P. Menarche i Danmark fra 1830'erne til 1983. Ugeskr Læger 1984;146:3902-4.
17. Olesen AW, Jeune B, Boldsen JL. Et fortsat fald i menarchealderen i Danmark. Ugeskr Læger 2001;163:5828-31.
18. Flint M. Is there a secular trend in age of menopause? Maturitas 1978;1:133-9.
19. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993;15:36-47.
20. Lambe M, Hsieh C, Trichopoulos D et al. Transient increase in the risk of breast cancer after giving birth. N Engl J Med 1994;331:5-9.
21. Wohlfahrt J, Olsen JH, Melby M. Breast cancer risk after childbirth in young women with family history (Denmark). Cancer Causes Control 2002;13:169-74.
22. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 2002;360:187-95.
23. Melbye M, Wohlfahrt J, Olsen JH et al. Induced abortion and the risk of breast cancer. N Engl J Med 1997;336:81-5.
24. Beral V, Bull D, Doll R et al. Breast cancer and abortion: collaborative re-analysis of data from 53 epidemiological studies, including 83,000 women with breast cancer from 16 countries. Lancet 2004;363:1007-16.
25. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002;94:606-16.
26. Micheli A, Muti P, Secreto G et al. Endogenous sex hormones and subsequent breast cancer in premenopausal women. Int J Cancer 2004;112:312-8.
27. Sturgeon SR, Potischman N, Malone KE et al. Serum levels of sex hormones and breast cancer risk in premenopausal women: a case-control study (USA). Cancer Causes Control 2004;15:45-53.
28. Calle EE, Rodriguez C, Walker-Thurmond K et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-38.
29. Hamajima N, Hirose K, Tajima K et al. Alcohol, tobacco and breast cancer - collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer arid 95,067 women without the disease. Br J Cancer 2002;87:1234-45.
30. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 1996;347:1713-27.
31. Venn A, Watson L, Bruinsma F et al. Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet 1999;354:1586-90.
32. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 1997;350:1047-59.
33. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419-27.
34. Colditz GA, Rosner BA, Chen WY et al. Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst 2004;96:218-28.
35. Tjønneland A, Christensen J, Thomsen BL et al. Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study. Cancer 2004;100:2328-37.
36. International Agency for Research on Cancer. Weight Control and Physical Activity. IARC Handbooks on Cancer Prevention 6. Lyon: IARC Press, 2002.
37. Key TJ, Allen NE, Spencer EA et al. Nutrition and breast cancer. Breast 2003;12:412-6.
38. Wohlfahrt J, Mouridsen H, Andersen PK et al. Reproductive risk factors for breast cancer by receptor status, histology, laterality and location. Int J Cancer 1999;81:49-55.
39. Huang WY, Newman B, Millikan RC et al. Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol 2000;151703-14.
40. Henderson BE, Bernstein L. The international variation in breast cancer rates: an epidemiological assessment. Breast Cancer Res Treat 1991;18(suppl 1):S11-S17.